The Patent Finder

Terms ending in 2034

Actelion Pharmaceuticals Ltd

Every in-force patent on Actelion Pharmaceuticals Ltd's record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,617,250PYRIDIN-4-YL Derivatives
In force
 · High confidence
Viatris Asia Pacific Pte. Ltd.In forceHigh confidence
US 9,422,249Preparation of Pyrimidine Intermediates Useful for the Manufacture of Macitentan
In force
 · High confidence
Actelion Pharmaceuticals Ltd.In forceHigh confidence
US 9,676,731Preparation of Pyrimidine Intermediates Useful for the Manufacture of Macitentan
In force
 · High confidence
Actelion Pharmaceuticals Ltd.In forceHigh confidence
US 9,556,125Process for Preparing a Pyrimidine Intermediate
In force
 · High confidence
Actelion Pharmaceuticals Ltd.In forceHigh confidence
US 10,259,8071-(PIPERAZIN-1-YL)-2-([1,2,4]TRIAZOL-1-YL)-ETHANONE Derivatives
In force
 · High confidence
Idorsia Pharmaceuticals Ltd.In forceHigh confidence
US 10,189,839Tricyclic Imidazole Compounds as Inhibitors of Tryptophan Hydroxylase
In force
 · High confidence
Actelion Pharmaceuticals Ltd.In forceHigh confidence
US 9,790,208Crystalline Salt Form of (S)-(2-(6-Chloro-7-Methyl-1H-BENZO[D]IMIDAZOL-2-YL)-2-Methylpyrrolidin-1-YL) (5-Methoxy-2-(2H-1,2,3-Triazol-2-YL)PHENYL)METHANONE as Orexin Receptor Antagonist
In force
 · High confidence
Idorsia Pharmaceuticals Ltd.In forceHigh confidence
US 9,914,720Crystalline Form of (S)-(2-(6-Chloro-7-Methyl-1H-BENZO[D]IMIDAZOL-2-YL)-2-Methylpyrrolidin-1 -YL)(5-Methoxy-2-(2H-1,2,3-Triazol-2-YL)PHENYL)METHANONE and Its Use as Orexin Receptor Antagonists
In force
 · High confidence
Idorsia Pharmaceuticals Ltd.In forceHigh confidence
US 10,023,560Crystalline Salt Form of (S)-(2-(6-Chloro-7-Methyl-1H-BENZO[D]IMIDAZOL-2-YL)-2-Methylpyrrolidin-1-YL)(5-Methoxy-2-(2H-1,2,3-Triazol-2-YL)PHENYL)METHANONE as Orexin Receptor Antagonist
In force
 · High confidence
Idorsia Pharmaceuticals Ltd.In forceHigh confidence
US 9,914,721Use of Benzimidazole-Proline Derivatives
In force
 · High confidence
Idorsia Pharmaceuticals Ltd.In forceHigh confidence
10 of 10 patents shown. Soonest term end first, then patent number.
4 of these are in force and held by Actelion Pharmaceuticals Ltd.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited